U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H8Cl3N3O4S2
Molecular Weight 380.656
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLORSULON

SMILES

NC1=C(C=C(C(=C1)C(Cl)=C(Cl)Cl)S(N)(=O)=O)S(N)(=O)=O

InChI

InChIKey=QOVTVIYTBRHADL-UHFFFAOYSA-N
InChI=1S/C8H8Cl3N3O4S2/c9-7(8(10)11)3-1-4(12)6(20(14,17)18)2-5(3)19(13,15)16/h1-2H,12H2,(H2,13,15,16)(H2,14,17,18)

HIDE SMILES / InChI

Molecular Formula C8H8Cl3N3O4S2
Molecular Weight 380.656
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Clorsulon is a compound belonging to the benzenesulphonamide family. It is used in veterinary medicine for the treatment of liver fluke (monotherapy), gasrtointestinal and lung worms, lice, grubs and mites (in combination with ivermectin) in cattles. Clorsulon inhibits the enzymes involved in the glycolytic pathways of the common liver fluke (Fasciola hepatica or Fasciola gigantica), namely phosphoglycerate kinase and phosphoglyceromutase.

Originator

Curator's Comment: # Merck

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Fasciola phosphoglycerate kinase
0.29 mM [Ki]
Target ID: Fasciola phosphoglyceromutase
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
CURATREM

Approved Use

For the treatment of immature and adult liver fluke (Fasciola hepatica) infestations in cattle.

Launch Date

9.8997122E11
Curative
IVOMEC

Approved Use

It is used for the treatment and control of gastrointestinal nematodes (adults and fourth-stage larvae) (Haemonchus placei, Ostertagia ostertagi (including inhibited larvae), O. lyrata, Trichostrongylus axei, T. colubriformis, Cooperia oncophora, C. punctate, C. pectinate, Oesophagostomum radiatum, Nematodirus helvetianus (adults only), N. spathiger (adults only), Bunostomum phlebotomum; lungworms (adults and fourth-stage larvae) (Dictyocaulus viviparous); liver flukes (adults only) (Fasciola hepatica); grubs (parasitic stages) (Hypoderma bovis, H. lineatum); lice (Linognathus vituli, Haematopinus eurysternus, Solenopotes capillatus); mites (Psoroptes ovis (syn. P. communis var. bovis), Sarcoptes scabiei var. bovis). It is also used to control infections of D. viviparous and O. radiatum for 28 days after treatment and O. ostertagi, T. axei and C. punctate for 21 days after treatment, and H. placei and C. oncophora, for 14 days after treatment.

Launch Date

6.0644157E11
Curative
IVOMEC

Approved Use

It is used for the treatment and control of gastrointestinal nematodes (adults and fourth-stage larvae) (Haemonchus placei, Ostertagia ostertagi (including inhibited larvae), O. lyrata, Trichostrongylus axei, T. colubriformis, Cooperia oncophora, C. punctate, C. pectinate, Oesophagostomum radiatum, Nematodirus helvetianus (adults only), N. spathiger (adults only), Bunostomum phlebotomum; lungworms (adults and fourth-stage larvae) (Dictyocaulus viviparous); liver flukes (adults only) (Fasciola hepatica); grubs (parasitic stages) (Hypoderma bovis, H. lineatum); lice (Linognathus vituli, Haematopinus eurysternus, Solenopotes capillatus); mites (Psoroptes ovis (syn. P. communis var. bovis), Sarcoptes scabiei var. bovis). It is also used to control infections of D. viviparous and O. radiatum for 28 days after treatment and O. ostertagi, T. axei and C. punctate for 21 days after treatment, and H. placei and C. oncophora, for 14 days after treatment.

Launch Date

6.0644157E11
Curative
IVOMEC

Approved Use

It is used for the treatment and control of gastrointestinal nematodes (adults and fourth-stage larvae) (Haemonchus placei, Ostertagia ostertagi (including inhibited larvae), O. lyrata, Trichostrongylus axei, T. colubriformis, Cooperia oncophora, C. punctate, C. pectinate, Oesophagostomum radiatum, Nematodirus helvetianus (adults only), N. spathiger (adults only), Bunostomum phlebotomum; lungworms (adults and fourth-stage larvae) (Dictyocaulus viviparous); liver flukes (adults only) (Fasciola hepatica); grubs (parasitic stages) (Hypoderma bovis, H. lineatum); lice (Linognathus vituli, Haematopinus eurysternus, Solenopotes capillatus); mites (Psoroptes ovis (syn. P. communis var. bovis), Sarcoptes scabiei var. bovis). It is also used to control infections of D. viviparous and O. radiatum for 28 days after treatment and O. ostertagi, T. axei and C. punctate for 21 days after treatment, and H. placei and C. oncophora, for 14 days after treatment.

Launch Date

6.0644157E11
Curative
IVOMEC

Approved Use

It is used for the treatment and control of gastrointestinal nematodes (adults and fourth-stage larvae) (Haemonchus placei, Ostertagia ostertagi (including inhibited larvae), O. lyrata, Trichostrongylus axei, T. colubriformis, Cooperia oncophora, C. punctate, C. pectinate, Oesophagostomum radiatum, Nematodirus helvetianus (adults only), N. spathiger (adults only), Bunostomum phlebotomum; lungworms (adults and fourth-stage larvae) (Dictyocaulus viviparous); liver flukes (adults only) (Fasciola hepatica); grubs (parasitic stages) (Hypoderma bovis, H. lineatum); lice (Linognathus vituli, Haematopinus eurysternus, Solenopotes capillatus); mites (Psoroptes ovis (syn. P. communis var. bovis), Sarcoptes scabiei var. bovis). It is also used to control infections of D. viviparous and O. radiatum for 28 days after treatment and O. ostertagi, T. axei and C. punctate for 21 days after treatment, and H. placei and C. oncophora, for 14 days after treatment.

Launch Date

6.0644157E11
Curative
IVOMEC

Approved Use

It is used for the treatment and control of gastrointestinal nematodes (adults and fourth-stage larvae) (Haemonchus placei, Ostertagia ostertagi (including inhibited larvae), O. lyrata, Trichostrongylus axei, T. colubriformis, Cooperia oncophora, C. punctate, C. pectinate, Oesophagostomum radiatum, Nematodirus helvetianus (adults only), N. spathiger (adults only), Bunostomum phlebotomum; lungworms (adults and fourth-stage larvae) (Dictyocaulus viviparous); liver flukes (adults only) (Fasciola hepatica); grubs (parasitic stages) (Hypoderma bovis, H. lineatum); lice (Linognathus vituli, Haematopinus eurysternus, Solenopotes capillatus); mites (Psoroptes ovis (syn. P. communis var. bovis), Sarcoptes scabiei var. bovis). It is also used to control infections of D. viviparous and O. radiatum for 28 days after treatment and O. ostertagi, T. axei and C. punctate for 21 days after treatment, and H. placei and C. oncophora, for 14 days after treatment.

Launch Date

6.0644157E11
PubMed

PubMed

TitleDatePubMed
The effect of ivomec super on dogs experimentally infested with Sarcoptes scabiei isolated from a patient.
2001 Apr
Ivermectin and clorsulon (ivomec super) in treatment of goats naturally infested with scab mites and biting lice.
2001 Aug
Efficacy of combined chemotherapy against gastrointestinal nematodes and Fasciola hepatica in cattle.
2001 Aug 20
Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica.
2001 Jun 9
Effects of parenteral administration of doramectin or a combination of ivermectin and clorsulon on control of gastrointestinal nematode and liver fluke infections and on growth performance in cattle.
2001 May 1
Effect of gastrointestinal nematode and liver fluke infections on weight gain and reproductive performance of beef heifers.
2002 Aug 2
Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes.
2003 Oct
Field trial on the efficacy of an experimental fasciolicide compared with some commercial compounds in naturally infected cattle.
2003 Sep
Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon.
2004 Feb
Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica.
2005 Feb
A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica.
2005 Jan
Field trial on comparative efficacy of four fasciolicides against natural liver fluke infection in cattle.
2006 Feb 18
Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke.
2006 Oct
The efficacy of antihelminthic compound; Clorsulon against experimental Schistosoma mansoni infection.
2007 Apr
Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.
2007 Apr
Comparison of the time required to administer three different fluke and worm combination products to commercial beef cattle at housing.
2008 Spring
Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle.
2009 Jun 10
Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells.
2010 Aug 5
Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.
2010 Feb 3
Patents

Sample Use Guides

Bovine liver fluke: one-quarter fluid ounce per 200 pounds of body weight (7 milligrams per kilogram or 3.2 milligrams per pound of body weight). 200 mcg ivermectin and 2 mg/kg body weight (1 mL/110 lb body weight). Bovine astrointestinal nematodes, lungworms, liver flukes, grubs, lice, and mites: 1 milliliter (10 milligrams of ivermectin and 100 milligrams of clorsulon) per 50 kilograms (110 pounds) as subcutaneous injection.
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:12:32 UTC 2023
Edited
by admin
on Fri Dec 15 15:12:32 UTC 2023
Record UNII
EG1ZDO6LRD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLORSULON
GREEN BOOK   INN   MART.   MI   USAN   USP   USP-RS  
USAN   INN  
Official Name English
CLORSULON [MART.]
Common Name English
CLORSULON [USP MONOGRAPH]
Common Name English
CLORSULON [USP-RS]
Common Name English
CURATREM
Brand Name English
4-AMINO-6-(TRICHLOROVINYL)-M-BENZENEDISULFONAMIDE
Common Name English
clorsulon [INN]
Common Name English
CLORSURON [JAN]
Common Name English
CLORSULON [USAN]
Common Name English
NSC-758901
Code English
CLORSULON [MI]
Common Name English
MK-401
Code English
1,3-BENZENEDISULFONAMIDE, 4-AMINO-6-(TRICHLOROETHENYL)-
Systematic Name English
CLORSULON [GREEN BOOK]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 522.1193
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
NCI_THESAURUS C250
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
CFR 21 CFR 520.462
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
CFR 21 CFR 556.163
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
Code System Code Type Description
EVMPD
SUB06767MIG
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
DAILYMED
EG1ZDO6LRD
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
RXCUI
28303
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY RxNorm
MESH
C015675
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
DRUG BANK
DB11389
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
USAN
T-6
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
ChEMBL
CHEMBL1474129
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
SMS_ID
100000084011
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
MERCK INDEX
m3665
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
262-100-2
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
NSC
758901
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
RS_ITEM_NUM
1140702
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
CAS
60200-06-8
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
PUBCHEM
43231
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
FDA UNII
EG1ZDO6LRD
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
INN
5237
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
NCI_THESAURUS
C75213
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
EPA CompTox
DTXSID8045488
Created by admin on Fri Dec 15 15:12:32 UTC 2023 , Edited by admin on Fri Dec 15 15:12:32 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY